Search for: "Watson Laboratories Inc."
Results 21 - 40
of 133
Sorted by Relevance
|
Sort by Date
27 Mar 2012, 8:51 am
Watson Laboratories, Inc., C.A. [read post]
27 Mar 2011, 9:28 pm
Watson Laboratories, Inc. [read post]
8 Jul 2011, 1:13 pm
In 2009, Reckitt Benckiser Inc. sued Watson Laboratories, Inc. - Florida for patent infringement related to Watson's filing of three Abbreviated New Drug Applications for generic versions of Reckitt's Mucinex(R) line of products. [read post]
19 Feb 2012, 8:55 pm
• Defendants: Watson Pharmaceuticals, Inc.; Watson Laboratories Inc. [read post]
11 Nov 2015, 4:51 am
In this patent infringement action, Watson Laboratories, Inc.'s ("Watson") moved to dismiss several counts of the complaint filed by Jazz Pharmaceuticals, Inc. and Jazz Pharmaceuticals Ireland Limited (collectively, "Jazz"). [read post]
3 Apr 2012, 9:15 am
Watson Laboratories, Inc. [read post]
1 Sep 2014, 10:00 pm
Watson Laboratories, Inc.), the Federal Circuit upheld the validity of the Orange Book-listed patents for Lysteda®, but found that they were not infringed by either Apotex’s or Watson’s Abbreviated New Drug Applications... [read post]
10 Dec 2010, 2:31 pm
Watson Laboratories, Inc., C.A. [read post]
14 May 2016, 6:24 am
The CAFC wrote:Watson Laboratories, Inc. [read post]
10 Jun 2014, 5:25 pm
ApotexApotex Inc., Apotex Corp., Sandoz, Inc., Hit-TechPharmacal Co., Inc., Actavis, Inc., Watson Laboratories,Inc., and Watson Pharma, Inc. [read post]
9 Mar 2008, 7:26 pm
Watson Laboratories, Inc. et al. 3:08-cv-00116; filed March 6, 2008 in the District Court of... [read post]
17 Feb 2010, 8:00 am
Watson Pharmaceuticals Inc., Watson Laboratories Inc. and Watson Pharma Inc. [read post]
7 Mar 2012, 4:54 am
., filed a patent infringement action against Watson Laboratory, Inc. [read post]
9 Aug 2009, 10:02 pm
The recalled patches are from Lot Number 145287A, have expiration dates of February 2011 and were manufactured by Watson Laboratories, Inc. and distributed by Watson Pharma, Inc. [read post]
27 Aug 2014, 10:00 pm
Watson Laboratories, Inc.), the Federal Circuit upheld the validity of the Orange Book-listed patents for Lysteda®, but found that they were not infringed by either Apotex’s or Watson’s Abbreviated New Drug Applications... [read post]
28 Feb 2010, 9:47 pm
Bio-Reference Laboratories, Inc. v. [read post]
20 May 2010, 9:55 pm
Court of Appeals for the Second Circuit ruled that the "pay-for-delay" agreement between defendants Bayer AG and several generic drugmakers (including The Rugby Group, Watson Pharmaceuticals Inc., and Barr Laboratories Inc.) were not illegal under U.S. antitrust law and prevailing precedent. [read post]
1 Apr 2016, 5:30 am
The FTC’s complaint alleges that Endo paid the first generic companies that filed for FDA approval – Impax Laboratories, Inc. and Watson Laboratories, Inc. [read post]
26 Aug 2012, 9:00 pm
Watson Laboratories, Inc. 3:12-cv-05228; filed August 20, 2012 in the District Court of New Jersey Infringement of U.S. [read post]
Court Of Appeals For Federal Circuit Denies Eli Lilly’s Appeal, Opens Door for Testosterone Generics
5 Dec 2017, 12:29 pm
., Actavis Laboratories UT, Inc., FKA Watson Laboratories Inc., Lupin Pharmaceuticals, Inc., and Lupin LTD infringed patent no. 8,435,944, Method and Composition for Transdermal Drug Delivery (the ‘944 patent) and 8,807,861, Spreading Implement, (the ‘861 patent), which have been issued by the US Patent Office. [read post]
